- Home
- BOX vs MDGL Comparison
BOX vs MDGL Comparison
Compare BOX & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOX
- MDGL
- Stock Information
- Founded
- BOX 2005
- MDGL 2011
- Country
- BOX United States
- MDGL United States
- Employees
- BOX N/A
- MDGL N/A
- Industry
- BOX Computer Software: Prepackaged Software
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- BOX Technology
- MDGL Health Care
- Exchange
- BOX Nasdaq
- MDGL Nasdaq
- Market Cap
- BOX 5.4B
- MDGL 6.1B
- IPO Year
- BOX 2015
- MDGL N/A
- Fundamental
- Price
- BOX $34.03
- MDGL $304.86
- Analyst Decision
- BOX Buy
- MDGL Strong Buy
- Analyst Count
- BOX 8
- MDGL 9
- Target Price
- BOX $38.50
- MDGL $420.63
- AVG Volume (30 Days)
- BOX 2.2M
- MDGL 305.4K
- Earning Date
- BOX 05-27-2025
- MDGL 08-06-2025
- Dividend Yield
- BOX N/A
- MDGL N/A
- EPS Growth
- BOX 77.37
- MDGL N/A
- EPS
- BOX 1.30
- MDGL N/A
- Revenue
- BOX $1,101,744,000.00
- MDGL $317,383,000.00
- Revenue This Year
- BOX $8.52
- MDGL $286.17
- Revenue Next Year
- BOX $7.44
- MDGL $64.17
- P/E Ratio
- BOX $26.31
- MDGL N/A
- Revenue Growth
- BOX 4.88
- MDGL N/A
- 52 Week Low
- BOX $24.63
- MDGL $200.63
- 52 Week High
- BOX $38.80
- MDGL $377.46
- Technical
- Relative Strength Index (RSI)
- BOX 43.26
- MDGL 61.70
- Support Level
- BOX $33.76
- MDGL $277.64
- Resistance Level
- BOX $34.86
- MDGL $314.22
- Average True Range (ATR)
- BOX 0.70
- MDGL 11.62
- MACD
- BOX -0.41
- MDGL 3.11
- Stochastic Oscillator
- BOX 7.22
- MDGL 82.64
About BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.